Evaluation of the pharmacokinetic drug-drug interaction between the antiretroviral agents fostemsavir and maraviroc: a single-sequence crossover study in healthy participants-Reference-Cited by-同舟云学术

Evaluation of the pharmacokinetic drug-drug interaction between the antiretroviral agents fostemsavir and maraviroc: a single-sequence crossover study in healthy participants

Published:2022-03-14 Issue:1 Volume:23 Page:1-8
ISSN:2578-7489
Container-title:HIV Research & Clinical Practice
language:en
Short-container-title:HIV Research & Clinical Practice

Author:

Wire Mary Beth¹^ORCID,Magee Mindy²,Ackerman Peter³,Llamoso Cyril³,Moore Katy¹^ORCID

Affiliation:

1. ViiV Healthcare, Research Triangle Park, NC, USA;

2. GlaxoSmithKline, Upper Providence, PA, USA

3. ViiV Healthcare, Branford, CT, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/25787489.2021.2016301

Reference25 articles.

1. Compartmental Absorption Modeling and Site of Absorption Studies to Determine Feasibility of an Extended-Release Formulation of an HIV-1 Attachment Inhibitor Phosphate Ester Prodrug

2. Nettles RE Chien C Elefant E et al. Single and multiple dose pharmacokinetics and safety in non‐HIV‐infected healthy subjects dosed with BMS‐663068 an oral HIV attachment inhibitor. Paper presented at: 12th International Workshop on Clinical Pharmacology of HIV Therapy; April 13–15 2011; Miami FL. Abstract O_04.

3. Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action

4. Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529

5. Lataillade M Krystal M Ackerman P. Conceptualization and design of mechanism of action for temsavir. Paper presented at: 16th European AIDS Conference; October 25–27 2017; Milan Italy. Abstract.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-05

2. Mechanism of action, resistance, interaction, pharmacokinetics, pharmacodynamics, and safety of fostemsavir;BMC Infectious Diseases;2024-02-23

3. Model‐Based Dose Selection of Fostemsavir for Pediatric Populations With Multidrug‐Resistant HIV‐1 and Relative Bioavailability Assessment in Healthy Adults;Clinical Pharmacology in Drug Development;2023-06-17